Purpose: Extranodal NK/T-cell lymphoma is an aggressive malignant disease which is associated with Epstein-Barr virus. Although several lines of evidence point at EBV as a key player in the pathogenesis of ENKTCL, the viral mechanism of entry into NK/T cells remains uncertain. Therefore, this study was conducted to identify the entry mechanism of EBV into NK/T cells. 
INTRODUCTION
Epstein-Barr virus (EBV), a member of the γ-herpesvirus family, is one of the most common viruses and persists in the vast majority of humans as a lifelong, asymptomatic infection within the B lymphocyte [1] . Extranodal NK/Tcell lymphoma, nasal type (ENKTCL) is the major group of natural killer (NK) cell neoplasms or more rarely, T cell neoplasms [2] . ENKTCL is a rare EBVassociated non-Hodgkin lymphoma (NHL) which affects the nasal cavity [3] and upper aerodigestive tract [4] . The transforming properties of EBV and its role in pathogenesis of a range of B cell malignancies are well established. By contrast, the association of this virus with malignancies of NK and T cell origin was entirely unexpected. Although a number of mature NK and T cell lymphoma subtypes have been related to EBV, evidence for a viral/tumor relationship is largely limited.
EBV is usually not detected in NK and T cells from the blood of healthy individuals but is reported to occur infrequently in tonsillar tissue infrequently following primary infection [5, 6] . EBV infects resting B cells via the CD21 and MHC class II co-receptor, and activated NK cells also express HLA-DR, but these cells do not express CD21. For this reason, the mechanism of EBV entry into NK cells remains uncertain [1] .
Exosomes-mediated transfer of mRNA from EBV-infected cells was proposed as a possible mechanism of viral entry into other cells [7, 8] . Exosomes are nanoparticles that are released from a wide variety of normal cells and malignant cells [9, 10] . Exosomes contain a wide variety of functional RNAs 3 including mRNA and miRNA [11] . Functional mRNAs also can be transferred to target cells where they are translated into proteins that modulate cellular signaling such as transcriptional factors, protein kinases, or metabolic enzymes [12] . Therefore we hypothesized that EBV-infected B cells-derived exosomes may transfer viral mRNA or CD21 mRNA into NK cells. We also investigated a possibility of transient membrane CD21 protein transfer (trogocytosis) which was also proposed as a possible mechanism of EBV entry into NK cells [13] . 
Exosome purification
Exosomes were isolated from supernatant of Raji cells by serial centrifugation and analyzed by Western blotting for protein staining or RT-PCR for viral gene detection. For large scale preparation of exosomes, cells were grown for 3 days in serum-free medium. 300ml of cell supernatant was collected and centrifuged at 1,500g for 10 min to sediment the cells and subsequently at 12,000g for 30min to remove the cellular debris. Cell supernatant was then 5 filtered over 0. 22 m and ultracentrifuged at 100,000g 8hr. The exosome pellet was washed once in a large volume of PBS and resuspended in PBS.
Flow cytometry
Flow cytometry analysis was performed using FACSCalibur (BD) to observe the trogocytosis of NKL cell line that co-cultured with Raji cell line, and the purity of NK cell populations isolated from PBMCs. All antibodies were from BD.
Virus production and purification
Epstein-Barr viruses were isolated from supernatant of B95-8 cell line by serial centrifugation. For large scale preparation of viruses, cells were grown for 4 then 300ml of cell supernatant was collected and centrifuged at 1,500g
for 10min to sediment the cells and subsequently at 12,000g for 30min to remove the cellular debris. Cell supernatant then filtered and stored at -80℃.
RT-PCR
Total RNA was isolated from the cells using an RNA Mini kit (Invitrogen) and reverse transcribed using SuperScript III reverse transcriptase (Invitrogen).
PCR amplification was performed using protocols with specific primers (Table 1) .
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RESULTS
Epstein-Barr virus did not infect NKL cells by exosomes
To elucidate the role of exosomes from EBV-positive B cells, we purified exosomes from Raji cell culture supernatant. Purity of isolated exosomes was confirmed by western blotting using organelle markers as shown in Fig 1A. Viral mRNAs (LMP1, EBNA1, and EBER1) were detected in Raji-derived exosomes ( Fig 1B, Rexo) as well as Raji cells (Raji). These EBV mRNAs were also detected in EBV-negative NK leukemia cell line NKL when the cells were treated with Raji-derived exosomes (Fig 1B, +Rexo) . However, expression of the EBV genes transferred from the Raji exosomes in NKL cells were diminished after 48hr (data not shown and Fig 1C) . As the CD21 mRNA in Raji exosomes was also transferred into NKL cells (Fig 1B) , we next tested the possibility that EBV infects NK cells via exosomes-derived CD21. As Raji cells are not producible its own virus, we treated viral supernatant from B95-8 cells to NKL cells with or without Raji exosomes. As shown in Fig 1C, however, after culture for 48hr, we did not see any viral mRNAs in NKL cells.
These data showed that mRNAs of EBV or viral entry receptor CD21 were transferred into NK cells, these are not sufficient to EBV persistency or EBV entry in NK cells. All experiments were performed more than five times independently and representative data are shown. (Fig 2A) .
Epstein-Barr virus does not infect NKL cells by CD21 trogocytosis
CD21 is expressed in all B cells including EBV-infected cells, and can be transferred into NK cells in immune synapse (i.e. trogocytosis). When NKL cells were co-cultured with
Raji cells, CD21 intensity was increased (Fig 2B) , however, in further cultivated NKL cells there were no EBV mRNA (Fig 2C) . Therefore, CD21
trogocytosis did not make EBV infection in NK cells in our experiments. 
Epstein-Barr virus enters NKL cells without EBV-positive B cells
EBV is an enveloped virus that contains viral DNA. Following primary infection, EBV usually persists within memory B cells in a latent state [1] . In latency 0 state, viral gene expression is mostly suppressed [15] . To identify the type of latent state, DNA from NK cells was extracted in previous experiments. Unexpectedly, EBV genes (LMP1, EBNA1, and EBER1) were found in all EBV treated NKL cells (Fig 3) . Interestingly, detection of EBV genes in NKL cells did not need B cell co-culture. 
Epstein-Barr virus infects primary NK cells
To confirm our finding in primary human NK cells, we isolated peripheral blood NK and B cells from 5 healthy donors, and treat EBV to the cells. After 14 days of culture, DNA from the samples was purified, and PCR analysis for viral DNA was performed. As shown in Figure 4 , EBER1 DNA was detected in NK cells, but LMP1 which was detected in B cells was not. [16] . Potential oncogenic effects of EBNA1 are considered to include promotion of EBV induced B cell immortalization [17] , induction of cellular genomic instability [18] , and protection from p53-mediated apoptosis [19] . LMP1 is the principal transforming protein of EBV. It functions as a classic oncogene in rodent fibroblast transformation assays and transformation of EBV-induced B cell in vitro [1] . LMP1 is also a key modulator of cell signaling, inducing expression of a number of antiapoptotic proteins, including BCL2 [20] and A20 (TNFAIP3) [21] , as well as adhesion molecules and activation antigens. The EBER1 transcripts are small non-coding RNA molecules that are the most highly expressed viral products in EBV-transformed cells. Their detection by in situ hybridization is a widely adopted assay to confirm EBV infection in fresh and fixed tissues. In B cells, some evidence indicates that EBER1 expression protects against apoptosis and contributes to cell transformation and proliferation [22] .
In this study, we demonstrated that EBV enters NK cells without interactions 
